SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 38 filers reported holding SCPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $139,545 | -38.8% | 19,599 | -12.5% | 0.00% | – |
Q2 2023 | $228,164 | +33.4% | 22,391 | +18.8% | 0.00% | – |
Q1 2023 | $171,000 | +45258.1% | 18,844 | -64.2% | 0.00% | – |
Q4 2022 | $377 | – | 52,582 | +375485.7% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 14 | -99.6% | 0.00% | – |
Q2 2021 | $19,000 | -85.0% | 3,174 | -83.3% | 0.00% | – |
Q1 2021 | $127,000 | +28.3% | 19,030 | +1.4% | 0.00% | – |
Q4 2020 | $99,000 | +153.8% | 18,759 | +268.4% | 0.00% | – |
Q3 2020 | $39,000 | +200.0% | 5,092 | +181.6% | 0.00% | – |
Q2 2020 | $13,000 | -95.7% | 1,808 | -95.6% | 0.00% | – |
Q1 2020 | $305,000 | +38.6% | 41,172 | +6.0% | 0.00% | – |
Q4 2019 | $220,000 | -21.7% | 38,848 | -18.2% | 0.00% | – |
Q3 2019 | $281,000 | +5520.0% | 47,489 | +2632.4% | 0.00% | – |
Q1 2019 | $5,000 | -28.6% | 1,738 | -6.6% | 0.00% | – |
Q4 2018 | $7,000 | -94.7% | 1,861 | -91.8% | 0.00% | – |
Q3 2018 | $133,000 | +1377.8% | 22,664 | +1268.6% | 0.00% | – |
Q2 2018 | $9,000 | -50.0% | 1,656 | +11.6% | 0.00% | – |
Q1 2018 | $18,000 | – | 1,484 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |